NeuroSense Therapeutics
Current Promotions
No video available
Get in Touch
About
Advancing research, development and therapy for ALS and additional CNS indications.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.
Currently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally.
$NRSN
Keywords
drug development, als, mnd, lou gehrigs disease, cns, biopharmaceuticals, neurodegenerative diseases, parkinsons disease, alzheimers disease, novel treatment
Amenities
No amenities listed yet
Upcoming Events
No upcoming events scheduled
Frequently Asked Questions
No FAQs available for this business.
Reviews
No reviews yet. Be the first to review!
Social Links
Photo Gallery
No photos available
Contact Information
Business Info
Location
Business Hours
Business hours not available
Own This Business?
Unclaimed
Take control of your business page to update information, respond to reviews, and more.
Claim This Business